Merck profit rises, cuts 2020 forecast over COVID-19 uncertainty

This post was originally published on this site
https://i-invdn-com.akamaized.net/trkd-images/LYNXNPEG3R10W_L.jpg

The company now expects its full-year adjusted profit forecast to be in the range of $5.17 to $5.37 per share, down from its prior estimates of between $5.62 and $5.77 per share.

Net income attributable to shareholders rose to $3.22 billion, or $1.26 per share, in the quarter, from $2.92 billion, or $1.12 per share, a year earlier.

Add Comment